118 related articles for article (PubMed ID: 37927237)
1. SNHG1, interacting with SND1, contributes to sorafenib resistance of liver cancer cells by increasing m6A-mediated SLC7A11 expression and promoting aerobic glycolysis.
Li R; Li S; Shen L; Li J; Zhang D; Yu J; Huang L; Liu N; Lu H; Xu M
Environ Toxicol; 2024 Mar; 39(3):1269-1282. PubMed ID: 37927237
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
Li W; Dong X; He C; Tan G; Li Z; Zhai B; Feng J; Jiang X; Liu C; Jiang H; Sun X
J Exp Clin Cancer Res; 2019 May; 38(1):183. PubMed ID: 31053148
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA SNHG1 activates glycolysis to promote hepatocellular cancer progression through the miR-326/PKM2 axis.
Wang Y; Yang F; Peng Q; Mei K; He H; Yang Q
J Gene Med; 2022 Aug; 24(8):e3440. PubMed ID: 35816558
[TBL] [Abstract][Full Text] [Related]
4. Expression of Long Non-Coding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) Exacerbates Hepatocellular Carcinoma Through Suppressing miR-195.
Zhang H; Zhou D; Ying M; Chen M; Chen P; Chen Z; Zhang F
Med Sci Monit; 2016 Dec; 22():4820-4829. PubMed ID: 27932778
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis.
Xu J; Xu Y; Ye G; Qiu J
J Chemother; 2023 Oct; 35(6):527-538. PubMed ID: 36548909
[TBL] [Abstract][Full Text] [Related]
6. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
8. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation.
Shi Z; Li Z; Jin B; Ye W; Wang L; Zhang S; Zheng J; Lin Z; Chen B; Liu F; Zhang B; Ding X; Yang Z; Shan Y; Yu Z; Wang Y; Chen J; Chen Q; Roberts LR; Chen G
Clin Transl Med; 2023 Jun; 13(6):e1300. PubMed ID: 37337470
[TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4.
Xiong X; Feng Y; Li L; Yao J; Zhou M; Zhao P; Huang F; Zeng L; Yuan L
Oncol Rep; 2020 May; 43(5):1503-1515. PubMed ID: 32323846
[TBL] [Abstract][Full Text] [Related]
10. METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability.
Xu Y; Bao Y; Qiu G; Ye H; He M; Wei X
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772373
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SNHG1 functions as a competitive endogenous RNA to regulate PDCD4 expression by sponging miR-195-5p in hepatocellular carcinoma.
Huang D; Wei Y; Zhu J; Wang F
Gene; 2019 Sep; 714():143994. PubMed ID: 31330233
[TBL] [Abstract][Full Text] [Related]
13. The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma.
Zeng Z; Wang J; Xu F; Hu P; Hu Y; Zhuo W; Chen D; Han S; Wang F; Zhao Y; Huang Y; Zhao G
Int J Biol Sci; 2024; 20(5):1744-1762. PubMed ID: 38481809
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer.
Zhang M; Yang L; Hou L; Tang X
Bioengineered; 2021 Dec; 12(2):9239-9250. PubMed ID: 34806925
[TBL] [Abstract][Full Text] [Related]
15. The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p.
Xu M; Chen X; Lin K; Zeng K; Liu X; Pan B; Xu X; Xu T; Hu X; Sun L; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2018 Sep; 17(1):141. PubMed ID: 30266084
[TBL] [Abstract][Full Text] [Related]
16. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma.
Zhang Z; Tan X; Luo J; Yao H; Si Z; Tong JS
Cell Death Dis; 2020 Oct; 11(10):902. PubMed ID: 33097691
[TBL] [Abstract][Full Text] [Related]
17. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR-454 and ZEB1.
Wu Y; Zhu B; Yan Y; Bai S; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
Mol Oncol; 2021 May; 15(5):1584-1596. PubMed ID: 33641229
[TBL] [Abstract][Full Text] [Related]
19. Small Nucleolar RNA Host Gene 1 (SNHG1) and Chromosome 2 Open Reading Frame 48 (C2orf48) as Potential Prognostic Signatures for Liver Cancer by Constructing Regulatory Networks.
Zhang H; Zhuo C; Zhou D; Zhang M; Zhang F; Chen M; Xu S; Chen Z
Med Sci Monit; 2020 Feb; 26():e920482. PubMed ID: 32036380
[TBL] [Abstract][Full Text] [Related]
20. SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer.
Li J; Zhang Z; Xiong L; Guo C; Jiang T; Zeng L; Li G; Wang J
Biochem Biophys Res Commun; 2017 May; 487(1):146-152. PubMed ID: 28400279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
